New immunosuppressive drugs in organ transplantation (Q41334079)

29 September 2017

1 reference

title

New immunosuppressive drugs in organ transplantation (English)

1 reference

29 September 2017

main subject

organ transplantation

1 reference

Hughes SE

1

1 reference

29 September 2017

Gruber SA

series ordinal

2

1 reference

29 September 2017

publication date

1 December 1996

1 reference

The Journal of Clinical Pharmacology

29 September 2017

published in

1 reference

29 September 2017

volume

36

1 reference

29 September 2017

issue

12

1 reference

29 September 2017

page(s)

1081-1092

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

The inhibition of nucleic acid synthesis by mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Cytostatic effect of deoxyspergualin on a murine leukemia cell line L1210.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

15-Deoxyspergualin: a novel immunosuppressive drug with clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

FK506 and deoxyspergualin: experimental studies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Deoxyspergualin for liver graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1996.TB04160.X

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.1002/J.1552-4604.1996.TB04160.X

1 reference

29 September 2017

1 reference